Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson's disease

Area of Science:

• Neuroimmunology
• Molecular Biology
• Neurodegenerative Diseases

Background:

• Microglia, the immune cells of the brain, have distinct activation states (M1/M2) influencing neuroinflammation in Parkinson's disease (PD).
• Modulating microglial polarization offers therapeutic potential for PD, but the underlying regulatory mechanisms are not fully understood.

Purpose of the Study:

• To investigate the role of the Kir6.1-containing ATP-sensitive potassium (Kir6.1/K-ATP) channel in regulating microglial polarization.
• To elucidate the mechanism by which Kir6.1/K-ATP channel influences neuroinflammation and dopaminergic neuron survival in PD.

Main Methods:

• Utilized Kir6.1 knockdown and overexpression in microglia to assess polarization.
• Examined the effects of Kir6.1 modulation on microglial activation states and inflammatory responses.
• Investigated the impact of Kir6.1 deficiency on dopaminergic neuron survival in a mouse model of PD.
• Analyzed the involvement of the p38 MAPK-NF-κB signaling pathway in Kir6.1-mediated effects.

Main Results:

• Kir6.1/K-ATP channel activation promoted M2 (beneficial) microglial polarization and suppressed M1 (detrimental) activation.
• Kir6.1 deficiency exacerbated dopaminergic neuron loss and M1 polarization in a PD mouse model.
• Kir6.1 deficiency enhanced p38 MAPK-NF-κB pathway activation, contributing to M1 polarization and neurotoxicity.
• Inhibition of p38 MAPK partially rescued the detrimental effects of Kir6.1 ablation.

Conclusions:

• The Kir6.1/K-ATP channel plays a critical role in modulating microglial phenotype transition from M1 to M2.
• This modulation occurs via the inhibition of the p38 MAPK-NF-κB signaling pathway.
• The Kir6.1/K-ATP channel represents a potential therapeutic target for Parkinson's disease.